Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Februar 2021

Planlagt Fastgjort Låst Flyttet Genmab
1.6k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #55

    AbbVie (ABBV) Q4 2020 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2021/02/03/abbvie-abbv-q4-2020-earnings-call-transcript/

    1 Reply Last reply
    0
    • D Offline
      D Offline
      Doublo
      wrote on sidst redigeret af
      #56

      March på stedet

      1 Reply Last reply
      0
      • Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktør
        wrote on sidst redigeret af
        #57

        Det kalder man base-dannelse. Er sundt for aktiekursen på den lange bane. 🙂

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #58

          Revlimid did $12.1bn in 2020, up +12% from 2019, Pomalyst $3.1bn up 22%

          1 Reply Last reply
          0
          • SolsenS Offline
            SolsenS Offline
            Solsen
            wrote on sidst redigeret af
            #59

            Roche https://www.roche.com/dam/jcr:e9d85f10-5ba5-4e8b-9535-eb8246b11641/en/irp210204.pdf Ritxan svigter nu. Ocrevus 4,3 bn CHF. Og meget mere læsestof.

            1 Reply Last reply
            0
            • D Offline
              D Offline
              deleted-user
              wrote on sidst redigeret af
              #60

              Umiddelbart holder TA omkring 2480, så kan Jan ellers slå vores sokker af med guide 2021 - jeg er klar med de lange skistrømper.

              1 Reply Last reply
              0
              • D Offline
                D Offline
                Doublo
                wrote on sidst redigeret af
                #61

                🙂

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #62

                  ADC Therapeutics Completes Enrollment in Pivotal Phase 2 Clinical Trial of Camidanlumab Tesirine (Cami) in Relapsed or Refractory Hodgkin Lymphoma https://www.businesswire.com/news/home/20210204005392/en/ADC-Therapeutics-Completes-Enrollment-in-Pivotal-Phase-2-Clinical-Trial-of-Camidanlumab-Tesirine-Cami-in-Relapsed-or-Refractory-Hodgkin-Lymphoma

                  1 Reply Last reply
                  0
                  • D Offline
                    D Offline
                    Doublo
                    wrote on sidst redigeret af
                    #63

                    EL spændende med alle de nye Genmab navne

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #64

                      WCLC 2020: Updates from the CHRYSALIS trial and what it means for patients with NSCLC
                      https://ecancer.org/en/video/9479-wclc-2020-updates-from-the-chrysalis-trial-and-what-it-means-for-patients-with-nsclc (amivantamab)

                      1 Reply Last reply
                      0
                      • BulderB Offline
                        BulderB Offline
                        Bulder
                        wrote on sidst redigeret af
                        #65

                        Sounds promising. Thx E L

                        1 Reply Last reply
                        0
                        • BulderB Offline
                          BulderB Offline
                          Bulder
                          wrote on sidst redigeret af
                          #66

                          Now, royalty is high single digit up till double digit. But have we seen any sales estimates?

                          1 Reply Last reply
                          0
                          • A Offline
                            A Offline
                            AaBforever
                            wrote on sidst redigeret af
                            #67

                            Spændende hvor bunden er....?

                            1 Reply Last reply
                            0
                            • G Offline
                              G Offline
                              gdn55
                              wrote on sidst redigeret af
                              #68

                              Eller toppen

                              1 Reply Last reply
                              0
                              • A Offline
                                A Offline
                                AaBforever
                                wrote on sidst redigeret af
                                #69

                                Jeps..bare der er meget længere til toppen end
                                der er til bunden..;-)

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #70

                                  JNJ has been calling it a potential blockbuster for years; I think they'll be able to make that just in NSCLC, but we know that 'Eligible tumor types include non-small cell lung cancer (NSCLC), squamous cell carcinoma of the head and neck (SCCHN), hepatocellular cancer (HCC), colorectal cancer (CRC), renal cell cancer (RCC), medullary thyroid cancer (MTC), gastroesophageal cancer (GEC), mesothelioma, breast cancer (BC) and ovarian cancer (OC)
                                  '

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #71

                                    it has Breakthrough Therapy Designation since march last year already, and they also have pre-approval access already which i hope will also help making this a fast approval

                                    1 Reply Last reply
                                    0
                                    • G Offline
                                      G Offline
                                      gdn55
                                      wrote on sidst redigeret af
                                      #72

                                      ÅaBfoever Min bund er 2000, så jeg er rimelig rolig nu.Jeg havde en drøm for mange år siden, og det var at Genmab kom i 2000, og hvis den kom det solgte jeg alle mine aktier. Men jeg har dem endnu, heldigvis.

                                      1 Reply Last reply
                                      0
                                      • Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktør
                                        wrote on sidst redigeret af
                                        #73

                                        Fest i Anavex tråden: https://www.proinvestor.com/boards/89244#postdiv90636

                                        1 Reply Last reply
                                        0
                                        • SolsenS Offline
                                          SolsenS Offline
                                          Solsen
                                          wrote on sidst redigeret af
                                          #74

                                          Personligt har jeg aldrig før oplevet at eje en aktie med +100% på dagsbasis. Og tak til Tasso1 og PI for, at være skribenten og stedet jeg lærte aktien at kende. Så ja en festdag 🙂

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger